Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BNNano is a private U.S. advanced materials company focused on the development and commercial manufacturing of boron nitride nanotubes and its proprietary NanoBarb nanomaterial. The company supplies engineered nanomaterials and masterbatch products designed to improve the thermal, mechanical, barrier, and other performance characteristics of polymers, metals, composites, textiles, and filtration media. Its technology is positioned primarily for industrial markets including aerospace, defense, automotive, energy, water filtration, and specialty materials, with biomedical applications mentioned as a potential end market rather than a core therapeutic pipeline. BNNano appears to operate as a platform materials company rather than a drug developer, with revenue likely driven by materials sales, application development, and related commercial partnerships.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BNNano.